The biological effects of eCBs are mediated mainly by two members of the G protein-coupled receptor family: CB1R and CB2R. CB1R is widely considered a potential therapeutic target in neuropsychological and neurodegenerative diseases; CB2R selectively regulates the function of immune cells. Here, CNR1 is linked to neurodegenerative disease.